Parkinson's Disease (PD)
30
8
10
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 30 trials
100.0%
+13.4% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (30)
Parkinson's Research In Metagenomic Early Stage Biomarkers
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
PET-MRI of Reward System in Parkinson's Disease With RBD
Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop
Full-Spectrum Cannabidiol Oil for Anxiety and Depressive Symptoms in Parkinson's Disease
The Meals Study for Amyotrophic Lateral Sclerosis and Parkinson's Disease
Relative Bioavailability Study of HNC364 Injectable Suspension
Attention and Eye Movement in Parkinson's Disease
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease
Mental Health Support for People Affected by Parkinson's
Low-Fidelity Driving Simulator Training in Parkinson's Disease.
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
Developing Immersive Gamification Technology Systems For The Rehabilitation Management Of Adults With Parkinson's Disease (Phase 1 Trial)
Accelerated TMS for Freezing of Gait in Parkinson's Disease
Prevention-in-PD-Study
Clozapine-related Immunodeficiency in Parkinsons Disease
rTMS Treatment of Dysphagia in Parkinson's Patients
The Effects of Dual Task Training With Different Task Priorities on Physical Performance and Cognitive Status in Patients With Parkinson's Disease
Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients